Evidence map›Paper›PMID 35848842›Full record

ArticleBlood advances2022

Quality of life, psychological distress, and prognostic perceptions in caregivers of patients with multiple myeloma.

Elizabeth K O'Donnell, Yael N Shapiro, Andrew J Yee, Omar Nadeem, Jacob P Laubach, Andrew R Branagan, Kenneth C Anderson, Clifton C Mo, Nikhil C Munshi, Irene M Ghobrial and 8 more

Abstract readMulticenter Study
In one paragraph

Article in Blood advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Observational
  3. Article
  4. Symptom distress and fear of progression associated with quality of life in multiple myeloma patients receiving treatment.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Elizabeth K O'DonnellMassachusetts General Hospital Cancer Center, Boston, MA.ORCID 0000-0002-4042-1526
Yael N ShapiroMassachusetts General Hospital Cancer Center, Boston, MA.
Andrew J YeeMassachusetts General Hospital Cancer Center, Boston, MA.ORCID 0000-0003-3623-7491
Omar NadeemHarvard Medical School, Boston, MA.
Jacob P LaubachHarvard Medical School, Boston, MA.ORCID 0000-0001-7565-2052
Andrew R BranaganMassachusetts General Hospital Cancer Center, Boston, MA.ORCID 0000-0002-3868-9267
Kenneth C AndersonHarvard Medical School, Boston, MA.
Clifton C MoHarvard Medical School, Boston, MA.
Nikhil C MunshiHarvard Medical School, Boston, MA.
Irene M GhobrialHarvard Medical School, Boston, MA.ORCID 0000-0001-7361-3092
Adam S SperlingHarvard Medical School, Boston, MA.
Emerentia A AgyemangMassachusetts General Hospital Cancer Center, Boston, MA.
Jill N BurkeMassachusetts General Hospital Cancer Center, Boston, MA.
Cynthia C HarringtonMassachusetts General Hospital Cancer Center, Boston, MA.
Bonnie Y HuMassachusetts General Hospital Cancer Center, Boston, MA.
Paul G RichardsonHarvard Medical School, Boston, MA.
Noopur S RajeMassachusetts General Hospital Cancer Center, Boston, MA.
Areej El-JawahriMassachusetts General Hospital Cancer Center, Boston, MA.

Funding

Dana Farber/Harvard Cancer Consortium Career Development Program in Clinical OncologyK12CA087723 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI David Tsai Ting · 2002 to 2026
$17.9M
Defining mechanisms of thalidomide analog resistanceK08CA252174 · NCI · DANA-FARBER CANCER INST · PI SPERLING, ADAM · 2020 to 2024
$1.3M
NCI NIH HHS K08 CA252174NCI NIH HHS K12 CA087723
6 · The paper itself

Abstract

Although caregivers of patients with multiple myeloma (MM) play a critical role in supporting their loved ones throughout the illness course, studies examining caregiver quality of life (QOL), psychological distress, and prognostic awareness are lacking. We conducted a cross-sectional, multisite study of patients undergoing treatment with MM and their caregivers. Eligible caregivers were enrolled to 1 of 3 cohorts based on lines of therapy. Caregivers completed validated questionnaires to assess their QOL, psychological distress, and perceptions of prognosis. We enrolled 127 caregivers of patients with MM (newly diagnosed [n = 43], 2-3 lines of therapy [n = 40], and ≥4 lines of therapy [n = 44]). Caregiver QOL and psychological distress did not differ by line of therapy. The rate of clinically significant anxiety, depression, and posttraumatic stress disorder symptoms were 44.1% (56/127), 15.8% (20/127), and 24.4% (31/127), respectively. When examined in dyads, caregivers reported higher rates of clinically significant anxiety (44.4% [55/124] vs 22.5% [28/124]) compared with patients with MM. Most caregivers (84.2%, 101/120) reported that the oncologist had informed them that the patient's cancer was incurable; however, only 50.9% (58/114) and 53.6% (59/110) of caregivers acknowledged the patient's cancer was terminal and incurable, respectively. Caregivers of patients undergoing treatment for MM experience substantial psychological distress across the disease continuum, particularly anxiety. The majority of caregivers of patients with MM report that knowing the patient's prognosis is extremely important and report that the oncologist told them that the patient was incurable. Nevertheless, a significant portion of caregivers believe that the patient's MM is curable.

Indexed as

Multiple MyelomaPsychological DistressCaregiversCross-Sectional StudiesDepressionHumansPrognosisQuality of Life

Identifiers

PMID35848842
PMCPMC9631626

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.